Natural history of early, localized prostate cancer

JAMA

Volumn 291, Issue 22, 2004, Pages 2713-2719

  Johansson, Jan Erik ^a   Andrén, Ove ^a   Andersson, Swen Olof ^a   Dickman, Paul W ^b   Holmberg, Lars ^c   Magnuson, Anders ^a   Adami, Hans Olov ^b,d  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d HARVARD CENTER FOR CANCER PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; DISEASE COURSE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; RISK ASSESSMENT; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; POISSON DISTRIBUTION; PROSTATE TUMOR; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASM STAGING; PHENOTYPE; POISSON DISTRIBUTION; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 2642548279     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.22.2713     Document Type: Article

References (26)

1. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994;330:242-248.
2. Adolfsson J, Steineck G, Hedlund PO. Deferred treatment of clinically localized low-grade prostate cancer: actual 10-year and projected 15-year follow-up of the Karolinska series. Urology. 1997;50:722-726.
3. Johansson JE, Holmberg L, Johansson S, Bergstrom R, Adami HO. Fifteen-year survival in prostate cancer: a prospective, population-based study in Sweden. JAMA. 1997;277:467-471.
4. Holmberg L, Bill-Axelson A, Helgesen F, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med. 2002;347:781-789.
5. TNM Classification of Malignant Tumors. Revised 3rd ed. Geneva, Switzerland: International Union Against Cancer; 1978.
6. World Health Organization. International Histological Classification of Tumors. Vol 22. Geneva, Switzerland: World Health Organization; 1980.
7. Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958;8:699-712.
8. Hakulinen T. On long-term relative survival rates. J Chronic Dis. 1977;30:431-443.
9. Clayton D, Hills M. Statistical Models in Epidemiology. Oxford, England: Oxford University Press; 1993.
10. Hakulinen T, Abeywickrama K. A computer program package for relative survival analysis. Comput Programs Biomed. 1985;19:197-207.
11. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003;33:49-54.
12. Bernards R, Weinberg RA. A progression puzzle. Nature. 2002;418:823.
13. Walsh PC, Lepor H. The role of radical prostatectomy in the management of prostatic cancer. Cancer. 1987;60(3 suppl):526-537.
14. Gerber GS, Thisted RA, Scardino PT, et al. Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA. 1996;276:615-619.
15. Blasko JC, Grimm PD, Sylsvester JE, Cavanagh W. The role of external beam radiotherapy with I-125/ Pd-103 brachytherapy for prostate carcinoma. Radiother Oncol. 2000;57:273-278.
16. Hanks GE, Hanlon AL, Pinover WH, Horwitz EM, Price RA, Schultheiss T. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys. 2000;46:823-832.
17. Oliver SE, Donovan JL, Peters TJ, Frankel S, Hamdy FC, Neal DE. Recent trends in the use of radical prostatectomy in England: the epidemiology of diffusion. BJU Int. 2003;91:331-336.
18. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA. 1995;274:626-631.
19. Aus G, Hugosson J, Norlen L. Long-term survival and mortality in prostate cancer treated with noncurative intent. J Urol. 1995;154(2 pt 1):460-465.
20. Borre M, Nerstrom B, Overgaard J. The natural history of prostate carcinoma based on a Danish population treated with no intent to cure. Cancer. 1997;80:917-928.
21. Helgesen F, Holmberg L, Johansson JE, Bergstrom R, Adami HO. Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst. 1996;88:1216-1221.
22. Adolfsson J, Oksanen H, Salo JO, Steineck G. Localized prostate cancer and 30 years of follow-up in a population-based setting. Prostate Cancer Prostatic Dis. 2000;3:37-42.
23. Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129-135.
24. Bishoff JT, Motley G, Optenberg SA, et al. Incidence of fecal and urinary incontinence following radical perineal and retropubic prostatectomy in a national population. J Urol. 1998;160:454-458.
25. Steineck G, Helgesen F, Adolfsson J, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med. 2002;347:790-796.
26. Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324:1156-1161.